Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_assertion type Assertion NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_head.
- NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_assertion description "[However, the feasibility to treat tumors in which the effect of the HGF-cMET signaling pathway is less unambiguous or may even be inhibitory on carcinogenesis, such as hepatocellular carcinoma (HCC) with NK4 needs further assessment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_provenance.
- NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_assertion evidence source_evidence_literature NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_provenance.
- NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_assertion SIO_000772 15905856 NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_provenance.
- NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_assertion wasDerivedFrom befree-20140225 NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_provenance.
- NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_assertion wasGeneratedBy ECO_0000203 NP913968.RAFmK3JZ5KPlfmS2dbONsrjnse65bZb0QrhXCQ3wNk1kk130_provenance.